EMA shortages Shortage resolved Medicine shortages
Respreeza — supply shortage (shortage resolved)
Published by European Medicines Agency:
Summary
Supply shortage
Medicine
Respreeza
- Category
- Medicine shortages
- Product type
- Human medicine
- Active substance (INN): alpha1-proteinase inhibitor (human)
- Therapeutic area: Genetic Diseases, Inborn;Lung Diseases
- Pharmaceutical forms affected: Powder and solvent for solution for infusion
- Strengths affected: 4,000 mg ;5,000 mg
- Last updated: 06/05/2021
Measures and alternatives
- Availability of alternatives: Yes
Source: EMA — medicine shortages — European Medicines Agency
Source: European Medicines Agency (EMA). Reproduced with acknowledgement of the source, in line with the EMA legal notice. EU Safety Radar is an independent information service; the text above presents the official data in the original language — the notice published by the authority is authoritative.
Open the original notice (www.ema.europa.eu) ↗